Doseology Sciences Inc. announced the appointment of Peter Geh as Chief Financial Officer, effective January 26, 2022. Peter spent over ten years in public practice accounting working with entities in the public, private and not-for-profit sectors. As VP Finance of a Canadian tech company, Peter oversaw revenue growth of over 400% and staff growth of 75% during a two-year period.

Ms. Marissen thanks Interim CFO Alex McAulay for his service to the Company.